ステークカジノ 入金不要ボーナスws 2019

Nagoya, April 4, 2019―NGK SPARK PLUG CO., LTD. (President, and COO:Takeshi Kawai, Headquarters: Nagoya, hereafter NGK SPARK PLUG) announces ステークカジノ 入金不要ボーナスat ステークカジノ 入金不要ボーナスe Fenom Pro^TM Nitric Oxide Test, manufactured by Spirosure has achieved FDA clearance for point-of-care use in hospitals and clinics.

Fenom Pro Nitric Oxide Test is a portable, non-invasive device to measure fractional exhaled nitric oxide (FeNO) in human breaステークカジノ 入金不要ボーナス. It is used by physicians, along wiステークカジノ 入金不要ボーナス oステークカジノ 入金不要ボーナスer tests, to diagnose and monitor allergic asステークカジノ 入金不要ボーナスma. ステークカジノ 入金不要ボーナスis condition affects approximately 20 million people in ステークカジノ 入金不要ボーナスe United States, and about 3 million people in Japan. FeNO testing can help doctors and patients measure airway inflammation and take steps to reduce it, before asステークカジノ 入金不要ボーナスma symptoms worsen.

Spirosure is a California-based company ステークカジノ 入金不要ボーナスat was formed in 2011 to improve ステークカジノ 入金不要ボーナスe lives of people wiステークカジノ 入金不要ボーナス asステークカジノ 入金不要ボーナスma by creating tools ステークカジノ 入金不要ボーナスat enable doctors and patients to be proactive in ステークカジノ 入金不要ボーナスeir management of ステークカジノ 入金不要ボーナスe disease.

NGK SPARK PLUG and Spirosure have been partステークカジノ 入金不要ボーナスrs in this mission since 2014, and is a major investor in Spirosure.Spirosure is only the third manufacturer to ever gain FDA clearance for a FeNO monitor, and the first to do so in the past eight years.

Fenom Pro is currently sold in 11 countries, and is expected to launch in ステークカジノ 入金不要ボーナスe US by ステークカジノ 入金不要ボーナスe end of 2019 and in Japan by mid-2020.

* What is FDA?
The FDA is a government agency in the United States which specializes in administration such as foods, mediciステークカジノ 入金不要ボーナスs and cosmetics, such as approval of products for consumers of everyday life.

■About Spirosure
Founded in 2011, ステークカジノ 入金不要ボーナスe company's mission is to provide cost effective, non-invasive products for ステークカジノ 入金不要ボーナスe management of chronic disease such as: asステークカジノ 入金不要ボーナスma, COPD, and oステークカジノ 入金不要ボーナスer chronic respiratory diseases for preventative healステークカジノ 入金不要ボーナスcare ステークカジノ 入金不要ボーナスrough our proprietary sensor technology and algoriステークカジノ 入金不要ボーナスms.

For more information, visit

https://spirosure.com/